Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKinsey
Moodys
Harvard Business School
Colorcon

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Deva Holding As Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for DEVA HOLDING AS, and what generic and branded alternatives to DEVA HOLDING AS drugs are available?

DEVA HOLDING AS has two approved drugs.



Summary for Deva Holding As
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Deva Holding As

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-006 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-002 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-003 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-001 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-004 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Deva Holding As ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 207181-001 Mar 6, 2017 AP RX No No   Start Trial   Start Trial
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-005 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Mallinckrodt
Merck
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.